CXCR3 and its ligands in a murine model of obliterative bronchiolitis: Regulation and function

Journal of Immunology

Volumn 176, Issue 11, 2006, Pages 7087-7095

  Medoff, Benjamin D ^a   Wain, John C ^a   Seung, Edward ^a   Jackobek, Ryan ^a   Means, Terry K ^a   Ginns, Leo C ^a   Farber, Joshua M ^b   Luster, Andrew D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; STAT1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS OBLITERANS; CONTROLLED STUDY; GENE DELETION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG TRANSPLANTATION; MEDIATOR; MOUSE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

EID: 33646865104     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.11.7087     Document Type: Article

References (64)

1. Trulock, E. 2001. Lung and heart-lung transplantation: overview of results. Semin. Respir. Crit. Care Med. 22: 479-488.
2. DeMeo, D. L., and L. C. Ginns. 2001. Clinical status of lung transplantation. Transplantation 72: 1713-1724.
3. Arcasoy, S. M., and R. M. Kotloff. 1999. Medical progress: lung transplantation. N. Engl. J. Med. 340: 1081-1091.
4. Boehler, A., S. Kesten, W. Weder, and R. Speich. 1998. Bronchiolitis obliterans after lung transplantation: a review. Chest 114: 1411-1426.
5. Sundaresan, S., E. P. Trulock, T. Mojanakumar, J. Cooper, and G. Patterson. 1995. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Ann. Thorac. Surg. 60: 1341-1346.
6. Girgis, R. E., I. Tu, G. J. Berry, H. Reichenspurner, V. G. Valentine, J. V. Conte, A. Ting, I. Johnstone, J. Miller, R. C. Robbins, et al. 1996. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J. Heart Lung Transplant. 15: 1200-1208.
7. Trulock, E. P., L. B. Edwards, D. O. Taylor, M. M. Boucek, B. M. Keck, and M. I. Hertz. 2005. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report-2005. J. Heart Lung Transplant. 24: 956-967.
8. Trulock, E. P. 1997. Lung transplantation. Am. J. Respir. Crit. Care Med. 155: 789-818.
9. Heng, D., L. D. Sharples, K. McNeil, S. Stewart, T. Wreghitt, and J. Wallwork. 1998. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J. Heart Lung Transplant. 17: 1255-1263.
10. Stewart, K. C., and G. A. Patterson. 2001. Current trends in lung transplantation. Am. J. Transplant. 1: 204-210.
11. Luster, A. D. 1998. Chemokines: chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338: 436-445.
12. Zlotnik, A., and O. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127.
13. Nelson, P. J., and A. M. Krensky. 2001. Chemokines, chemokine receptors, and allograft rejection. Immunity 14: 377-386.
14. Belperio, J. A., M. P. Keane, M. D. Burdick, J. P. Lynch III, Y. Y. Xue, K. Li, D. J. Ross, and R. M. Strieter. 2002. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J. Immunol. 169: 1037-1049.
15. + T cell as a major pathogenic factor in ischemic acute renal failure. J. Clin. Invest. 108: 1283-1290.
16. De Perrot, M., K. Young, Y. Imai, M. Liu, T. K. Waddell, S. Fischer, L. Zhang, and S. Keshavjee. 2003. Recipient T cells mediate reperfusion injury after lung transplantation in the rat. J. Immunol. 171: 4995-5002.
17. Medoff, B. D., E. Seung, J. C. Wain, T. K. Means, G. S. Campanella, S. A. Islam, S. Y. Thomas, L. C. Ginns, N. Grabie, A. H. Lichtman, et al. 2005. BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation. J. Exp. Med. 202: 97-110.
18. El-Sawy, T., N. M. Fahmy, and R. L. Fairchild. 2002. Chemokines: directing leukocyte infiltration into allografts. Curr. Opin. Immunol. 14: 562-568.
19. Agostini, C., F. Calabrese, F. Rea, M. Facco, A. Tosoni, M. Loy, G. Binotto, M. Valente, L. Trentin, and G. Semenzato. 2001. CXCR3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am. J. Pathol. 158: 1703-1711.
20. Belperio, J. A., M. D. Burdick, M. P. Keane, Y. Y. Xue, J. P. Lynch III, B. L. Daugherty, S. L. Kunkel, and R. M. Strieter. 2000. The role of the CC chemokine, RANTES, in acute lung allograft rejection. J. Immunol. 165: 461-472.
21. Kapoor, A., K. Morita, T. M. Engeman, E. M. Vapnek, M. Hobart, A. C. Novick, and R. L. Fairchild. 2000. Intragraft expression of chemokine gene occurs early during acute rejection of allogeneic cardiac grafts. Transplant. Proc. 32: 793-795.
22. Watarai, Y., S. Koga, D. R. Paolone, T. M. Engeman, C. Tannenbaum, T. A. Hamilton, and R. L. Fairchild. 2000. Intraallograft chemokine RNA and protein during rejection of MHC-matched/multiple minor histocompatibility-disparate skin grafts. J. Immunol. 164: 6027-6033.
23. + T cells. Transplantation 69: 1147-1155.
24. Melter, M., A. Exeni, M. E. J. Reinders, J. C. Fang, G. McMahon, P. Ganz, W. W. Hancock, and D. M. Briscoe. 2001. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation 104: 2558-2564.
25. Hancock, W. W., W. Gao, V. Csizmadia, K. L. Faia, N. Shemmeri, and A. D. Luster. 2001. Donor-derived IP-10 initiates development of acute allograft rejection. J. Exp. Med. 193: 975-980.
26. Zhang, Z., L. Kaptanoglu, W. Haddad, D. Ivancic, Z. Alnadjim, S. Hurst, D. Tishler, A. D. Luster, T. A. Barrett, and J. Fryer. 2002. Donor T cell activation initiates small bowel allograft rejection through an IFN-γ-inducible protein-10-dependent mechanism. J. Immunol. 168: 3205-3212.
27. Hancock, W. W., B. Lu, W. Gao, V. Csizmadia, K. Faia, J. A. King, S. T. Smiley, M. Ling, N. P. Gerard, and C. Gerard. 2000. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 192: 1515-1520.
28. Miura, M., K. Morita, H. Kobayashi, T. A. Hamilton, M. D. Burdick, R. M. Strieter, and R. L. Fairchild. 2001. Monokine induced by IFN-γ is a dominant factor directing T cells into murine cardiac allografts during acute rejection. J. Immunol. 167: 3494-3504.
29. Park, M. K., D. Amichay, P. Love, E. Wick, F. Liao, A. Grinberg, R. L. Rabin, H. H. Zhang, S. Gebeyehu, T. M. Wright, et al. 2002. The CXC chemokine murine monokine induced by IFN-γ (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo. J. Immunol. 169: 1433-1443.
30. Dufour, J. H., M. Dziejman, M. T. Liu, J. H. Leung, T. E. Lane, and A. D. Luster. 2002. IFN-γ-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168: 3195-3204.
31. Minamoto, K., and D. J. Pinsky. 2002. Recipient iNOS but not eNOS deficiency reduces luminal narrowing in tracheal allografts. J. Exp. Med. 196: 1321-1333.
32. Hertz, M. I., J. Jessurun, M. B. King, S. K. Savik, and J. J. Murray. 1993. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am. J. Pathol. 142: 1945-1951.
33. Belperio, J. A., M. P. Keane, M. D. Burdick, J. P. Lynch III, Y. Y. Xue, A. Berlin, D. J. Ross, S. L. Kunkel, I. F. Charo, and R. M. Strieter. 2001. Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. J. Clin. Invest. 108: 547-556.
34. Snyder, J. G., R. Prewitt, J. Campsen, and L. D. Britt. 2002. PDTC and Mg132, inhibitors of NF-κB, block endotoxin induced vasodilation of isolated rat skeletal muscle arterioles. Shock 17: 304-307.
35. Ziegler-Heitbrock, H. W., T. Sternsdorf, J. Liese, B. Belohradsky, C. Weber, A. Wedel, R. Schreck, P. Bauerle, and M. Strobel. 1993. Pyrrolidine dithiocarbamate inhibits NF-κB mobilization and TNF production in human monocytes. J. Immunol. 151: 6986-6993.
36. Kratsovnik, E., Y. Bromberg, O. Sperling, and E. Zoref-Shani. 2005. Oxidative stress activates transcription factor NF-κB-mediated protective signaling in primary rat neuronal cultures. J. Mol. Neurosci. 26: 27-32.
37. + regulatory T cells from mouse to man. Scand. J. Immunol. 62: 1-15.
38. + T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J. Exp. Med. 201: 1037-1044.
39. Belperio, J. A., M. P. Keane, M. D. Burdick, J. P. Lynch III, D. A. Zisman, Y. Y. Xue, K. Li, A. Ardehali, D. J. Ross, and R. M. Strieter. 2003. Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection. J. Immunol. 171: 4844-4852.
40. Yokota, N., F. Daniels, J. Crosson, and H. Rabb. 2002. Protective effect of T cell depletion in murine renal ischemia-reperfusion injury. Transplantation 74: 759-763.
41. Rabb, H. 2002. The T cell as a bridge between innate and adaptive immune systems: implications for the kidney. Kidney Int. 61: 1935-1946.
42. + T lymphocytes mediate ischemia/reperfusion- induced inflammatory responses in mouse liver. J. Clin. Invest. 100: 279-289.
43. Zhai, Y., X. D. Shen, R. O'Connell, F. Gao, C. Lassman, R. W. Busuttil, G. Cheng, and J. W. Kupiec-Weglinski. 2004. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J. Immunol. 173: 7115-7119.
44. Fisher, A. J., J. Wardle, J. H. Dark, and P. A. Corris. 2002. Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS). J. Heart Lung Transplant. 21: 1206-1212.
45. Christie, J. D., R. M. Kotloff, V. N. Ahya, G. Tino, A. Pochettino, C. Gaughan, E. Demissie, and S. E. Kimmel. 2005. The effect of primary graft dysfunction on survival after lung transplantation. Am. J. Respir. Crit. Care Med. 171: 1312-1316.
46. Farber, J. M. 1990. A macrophage mRNA selectively induced by γ-interferon encodes a member of the platelet factor 4 family of cytokines. Proc. Natl. Acad. Sci. USA 87: 5238-5242.
47. Wright, T. M., and J. M. Farber. 1991. 5′ Regulatory region of a novel cytokine gene mediates selective activation by interferon γ. J. Exp. Med. 173: 417-422.
48. Wong, P., C. W. Severns, N. B. Guyer, and T. M. Wright. 1994. A unique palindromic element mediates γ interferon induction of Mig gene expression. Mol. Cell. Biol. 14: 914-922.
49. Guyer, N. B., C. W. Severns, P. Wong, C. A. Feghali, and T. M. Wright. 1995. IFN-γ induces a p91/Stat1α-related transcription factor with distinct activation and binding properties. J. Immunol. 155: 3472-3480.
50. Ohmori, Y., R. D. Schreiber, and T. A. Hamilton. 1997. Synergy between interferon-γ and tumor necrosis factor-α in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor κB. J. Biol. Chem. 272: 14899-14907.
51. Majumder, S., L. Z. Zhou, P. Chaturvedi, G. Babcock, S. Aras, and R. M. Ransohoff. 1998. p48/STAT-1α-containing complexes play a predominant role in induction of IFN-γ-inducible protein, 10 kDa (IP-10) by IFN-γ alone or in synergy with TNF-α. J. Immunol. 161: 4736-4744.
52. Mahalingam, S., G. Chaudhri, C. L. Tan, A. John, P. S. Foster, and G. Karupiah. 2001. Transcription of the interferon γ (IFN-γ)-inducible chemokine Mig in IFN-γ-deficient mice. J. Biol. Chem. 276: 7568-7574.
53. Kawai, T., O. Takeuchi, T. Fujita, J. Inoue, P. F. Muhlradt, S. Sato, K. Hoshino, and S. Akira. 2001. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167: 5887-5894.
54. Ross, S. D., I. L. Kron, J. J. Gangemi, K. S. Shockey, M. Stoler, J. A. Kern, C. G. Tribble, and V. E. Laubach. 2000. Attenuation of lung reperfusion injury after transplantation using an inhibitor of nuclear factor-κB. Am. J. Physiol. 279: L528-L536.
55. Haddad, J. J. 2002. Science review: redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: role for nuclear factor-κB. Crit. Care 6: 481-490.
56. Craig, K., and D. Dorscheid. 2002. Understanding the roles of the transcription factors nuclear factor-κB and hypoxia-inducible factor-1α in lung injury. Crit. Care 6: 471-472.
57. Majumder, S., L. Z. Zhou, P. Chaturvedi, G. Babcock, S. Aras, and R. M. Ransohoff. 1998. Regulation of human IP-10 gene expression in astrocytoma cells by inflammatory cytokines. J. Neurosci. Res. 54: 169-180.
58. Bradley, J. A., and E. M. Bolton. 1992. The T-cell requirements for allograft rejection. Transplant. Rev. 6: 115-129.
59. Tullius, S. G., and N. L. Tilney. 1995. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 59: 313-318.
60. Waaga, A. M., M. Gasser, I. Laskowski, and N. L. Tilney. 2000. Mechanisms of chronic rejection. Curr. Opin. Immunol. 12: 517-521.
61. Rabinowich, H., A. Zeevi, I. L. Paradis, S. A. Yousem, J. H. Dauber, R. Kormos, R. L. Hardesty, B. P. Griffith, and R. J. Duquesnoy. 1990. Proliferative responses of bronchoalveolar lavage lymphocytes from heart-lung transplant patients. Transplantation 49: 115-121.
62. Rabinowich, H., A. Zeevi, S. A. Yousem, I. L. Paradis, J. H. Dauber, R. Kormos, R. L. Hardesty, B. P. Griffith, and R. J. Duquesnoy. 1991. Alloreactivity of lung biopsy and bronchoalveolar lavage derived lymphocytes from pulmonary transplant patients: correlations with acute rejection and bronchiolitis obliterans. Clin. Transplant. 4: 376.
63. Belperio, J. A., K. Lake, H. Tazelaar, M. P. Keane, R. M. Stricter, and J. P. Lynch. 2003. Bronchiolitis obliterans syndrome complicating lung or heart-lung transplantation. Semin. Respir. Crit. Care Med. 24: 499-530.
64. Duquesnoy, R. J., J. D. Trager, and A. Zeevi. 1991. Propagation and characterization of lymphocytes from transplant biopsies. Crit. Rev. Immunol. 10: 455-480.